Related references
Note: Only part of the references are listed.Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial
Karin Fjorden et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Prognostic mutational subtyping in de novo diffuse large B-cell lymphoma
Eugene Kim et al.
BMC CANCER (2022)
SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2022)
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
Wyndham H. Wilson et al.
CANCER CELL (2021)
Interplay between protein acetylation and ubiquitination controls MCL1 protein stability
Kouhei Shimizu et al.
CELL REPORTS (2021)
Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma
Victoria M. Smith et al.
HAEMATOLOGICA (2020)
Single-agent activity of phosphatidylinositol 3-kinase inhibition with copanlisib in patients with molecularly defined relapsed or refractory diffuse large B-cell lymphoma
Georg Lenz et al.
LEUKEMIA (2020)
A Regulatory Circuit Controlling the Dynamics of NFκB cRel Transitions B Cells from Proliferation to Plasma Cell Differentiation
Koushik Roy et al.
IMMUNITY (2019)
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL
Kamil Bojarczuk et al.
BLOOD (2019)
Systems analysis of phosphorylation-regulated Bcl-2 interactions establishes a model to reconcile the controversy over the significance of Bcl-2 phosphorylation
Ting Song et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Nongenetic origins of cell-to-cell variability in B lymphocyte proliferation
Simon Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia
Adriana E. Tron et al.
NATURE COMMUNICATIONS (2018)
Subcellular Localization and Dynamics of the Bcl-2 Family of Proteins
Nikolay Popgeorgiev et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2018)
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Matthew S. Davids et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Quantitative interactome of a membrane Bcl-2 network identifies a hierarchy of complexes for apoptosis regulation
Stephanie Bleicken et al.
NATURE COMMUNICATIONS (2017)
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment
Meike Vogler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
BCL2: A promising cancer therapeutic target
Gudapureddy Radha et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2017)
Targeting of BCL2 Family Proteins with ABT-199 and Homoharringtonine Reveals BCL2-and MCL1-Dependent Subgroups of Diffuse Large B-Cell Lymphoma
Magdalena Klanova et al.
CLINICAL CANCER RESEARCH (2016)
BH3 profiling and a toolkit of BH3-mimetic drugs predict anti-apoptotic dependence of cancer cells
Michael Butterworth et al.
BRITISH JOURNAL OF CANCER (2016)
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
Yong Hwa Eom et al.
JOURNAL OF BREAST CANCER (2016)
Mutation-induced protein interaction kinetics changes affect apoptotic network dynamic properties and facilitate oncogenesis
Linjie Zhao et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata et al.
CANCER DISCOVERY (2015)
Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth
Leila Haery et al.
MOLECULAR CANCER (2014)
A draft map of the human proteome
Min-Sik Kim et al.
NATURE (2014)
From computational modelling of the intrinsic apoptosis pathway to a systems-based analysis of chemotherapy resistance: achievements, perspectives and challenges in systems medicine
M. L. Wuerstle et al.
CELL DEATH & DISEASE (2014)
Systems Analysis of BCL2 Protein Family Interactions Establishes a Model to Predict Responses to Chemotherapy
Andreas U. Lindner et al.
CANCER RESEARCH (2013)
Characterizing the Relationship between Steady State and Response Using Analytical Expressions for the Steady States of Mass Action Models
Paul Michael Loriaux et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
BCL2 mutations in diffuse large B-cell lymphoma
J. M. Schuetz et al.
LEUKEMIA (2012)
A Unified Model of Mammalian BCL-2 Protein Family Interactions at the Mitochondria
Fabien Llambi et al.
MOLECULAR CELL (2011)
Regulation of Mitochondrial Apoptotic Events by p53-mediated Disruption of Complexes between Antiapoptotic Bcl-2 Members and Bim
Jie Han et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Still embedded together binding to membranes regulates Bcl-2 protein interactions
B. Leber et al.
ONCOGENE (2010)
Two Independent Positive Feedbacks and Bistability in the Bcl-2 Apoptotic Switch
Jun Cui et al.
PLOS ONE (2008)
Modeling a Snap-Action, Variable-Delay Switch Controlling Extrinsic Cell Death
John G. Albeck et al.
PLOS BIOLOGY (2008)
Modeling of the role of a bax-activation switch in the mitochondrial apoptosis decision
Chun Chen et al.
BIOPHYSICAL JOURNAL (2007)
Systems analysis of effector caspase activation and its control by X-linked inhibitor of apoptosis protein
Markus Rehm et al.
EMBO JOURNAL (2006)
Bistability in apoptosis: Roles of Bax, Bcl-2, and mitochondrial permeability transition pores
EZ Bagci et al.
BIOPHYSICAL JOURNAL (2006)
Mathematical modeling identifies inhibitors of apoptosis as mediators of positive feedback and bistability
Stefan Legewie et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Knockdown of p53 levels in human keratinocytes accelerates Mcl-1 and Bcl-xL reduction thereby enhancing UV-light induced apoptosis
V Chaturvedi et al.
ONCOGENE (2005)
Mathematical modeling of the regulation of caspase-3 activation and degradation
JW Stucki et al.
JOURNAL OF THEORETICAL BIOLOGY (2005)
Mathematical modeling reveals threshold mechanism in CD95-induced apoptosis
M Bentele et al.
JOURNAL OF CELL BIOLOGY (2004)
Bistability analyses of a caspase activation model for receptor-induced apoptosis
T Eissing et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-like diffuse large B-cell lymphoma
J Iqbal et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
A mathematical model of caspase function in apoptosis
M Fussenegger et al.
NATURE BIOTECHNOLOGY (2000)
Share Paper
